Is Catheter Precision Inc. (VTAK) overvalued? · rev $1.5M
Catheter Precision Inc. (VTAK) is a medical devices company listed on US.
This page asks whether Catheter Precision Inc. (VTAK) looks expensive on cached numbers — not a short thesis.
Latest reported VTAK revenue for 2026-06-30 was $1.5M. Net income was -$5.0M. VTAK currently screens at market cap $3.0M.
VTAK currently screens at market cap $3.0M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next VTAK 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the VTAK stock page for the full model, not this heading.
Not investment advice.